It is a healthcare private limited company based in Baramati, Maharashtra, India, established in 2011.
2011 | Baramati, Maharashtra, India | ActiveNishkarsh Ct Scan Diagnostic & Research Centre Private Limited, a active private limited company, was established on 06 September 2011 in Baramati, Maharashtra, India. Engaging in other hospital and medical care activities within the hospital and medical care sector, it holds CIN: U85100PN2011PTC140642. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹4.00 M and a paid-up capital of ₹3.95 M.
It upholds a compliant status. Its leadership includes Sachin Anandrao Balgude (Director), Rahul Namdeo Tupe (Director), Pandurang Sambhaji Gawade (Director). It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 54/2, Sr. No. 35/1, Gawade Hospital, Devale Estate, Gunavadi Road,, Baramati, Maharashtra, 413102.
U85100PN2011PTC140642
140642
06 September 2011
₹4.00 M
₹3.95 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sachin Anandrao Balgude | Director | 06 Sep 2011 | Current |
| Rahul Namdeo Tupe | Director | 06 Sep 2011 | Current |
| Pandurang Sambhaji Gawade | Director | 06 Sep 2011 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited, for the financial year ended 2017, experienced modest growth in revenue, with a 1.33% increase. The company also saw a substantial improvement in profitability, with a 90.23% increase in profit. The company's net worth dipped by a decrease of 0.49%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Nishkarsh Ct Scan Diagnostic & Research Centre had a promoter holding of 41.11% and a public holding of 58.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2012 | Hdfc Bank Limited | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Nishkarsh Ct Scan Diagnostic & Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Nishkarsh Ct Scan Diagnostic & Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nishkarsh Ct Scan Diagnostic & Research Centre's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Progress on Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 5.00 M with Charge ID 10381747 was registered on 27 Sep 2012. was documented.
Sachin Anandrao Balgude was appointed as a Director was appointed as a Director on 06 Sep 2011 & has been associated with this company since 14 years 2 months . was recorded as a recent event.
Rahul Namdeo Tupe was appointed as a Director was appointed as a Director on 06 Sep 2011 & has been associated with this company since 14 years 2 months . was recorded as a recent event.
Progress on Pandurang Sambhaji Gawade was appointed as a Director was appointed as a Director on 06 Sep 2011 & has been associated with this company since 14 years 2 months . was documented.
The CIN of Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited is U85100PN2011PTC140642.
Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited is headquartered at Plot No. 54/2, Sr. No. 35/1, Gawade Hospital, Devale Estate, Gunavadi Road,, Baramati, Maharashtra, 413102.
Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited was incorporated on 06 September 2011.
The current directors of Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited are
The primary industry of Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited is Hospital And Medical Care.
Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited is unlisted.
The authorized capital of Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited is ₹4.00 M, and the paid-up capital is ₹3.95 M.
The compliance status of Nishkarsh Ct Scan Diagnostic & Research Centre Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX